One noteworthy feature of the innovation of the organisation of services in the English NHS is the fascination with the US and the borrowing of its ideas, models of care, […]
Year: 2018
Chris Ham and Anna Charles: Accountable care is a promising way of integrating care
Campaigners have launched judicial reviews of a proposed contract designed to enable NHS commissioners to procure care from accountable care organisations. The contract would allow these organisations to take responsibility […]
Charlie Massey: We are committed to making health services a place for learning, not blaming
The Bawa-Garba case has been tragic: a family lost their son in terrible circumstances and a doctor lost her career. I know there is concern and anger about this issue, […]
Eric D Perakslis: It’s time to address the medical benefits and risks of the internet of things
It’s time for us to seriously consider which patient care and monitoring devices should be connected to the internet […]
Rachel Clarke: The Hadiza Bawa-Garba case is a watershed for patient safety
We need the GMC to set a powerful precedent by speaking up about the dangers of rota gaps, says Rachel Clarke […]
Sebastian Walsh: Refusing “ash cash”
The completion of a cremation form is a service that takes time and knowledge, and in any other walk of life a service demands payment. But I am not in […]
Avoiding blame and liability is vital to learning from errors and engineering a safer NHS
Helgi Johannsson and William Rook Hadiza Bawa-Garba, a trainee paediatrician who was convicted of gross negligence manslaughter over the death of Jack Adcock, a 6 year old boy, was struck […]
Richard Lehman’s journal review—29 January 2018
Richard Lehman reviews the latest research in the top medical journals […]
Jeffrey Aronson: When I Use a Word . . . Adrenaline and epinephrine
Most therapeutic medicines have at least three different names. The chemical name, whose form generally follows the rules issued by the International Union of Pure and Applied Chemistry (IUPAC). For […]
Giorgia Sulis: Delamanid—a broken dream for patients with MDR-TB?
After decades of neglect by the drugs industry, the fight against tuberculosis will be even harder now that delamanid’s role seems to be rather limited […]